Stock DNA
Pharmaceuticals & Biotechnology
HKD 13,062 Million ()
NA (Loss Making)
NA
0.71%
-0.65
-7.60%
2.72
Revenue and Profits:
Net Sales:
203 Million
(Quarterly Results - Jun 2009)
Net Profit:
65 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.56%
0%
-21.56%
6 Months
12.93%
0%
12.93%
1 Year
84.51%
0%
84.51%
2 Years
101.54%
0%
101.54%
3 Years
25.96%
0%
25.96%
4 Years
-16.56%
0%
-16.56%
5 Years
48.86%
0%
48.86%
Sihuan Pharmaceutical Holdings Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.18%
EBIT Growth (5y)
-193.65%
EBIT to Interest (avg)
7.73
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.33
Tax Ratio
10.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.59%
ROE (avg)
1.99%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.93
EV to EBIT
-23.79
EV to EBITDA
-60.16
EV to Capital Employed
6.77
EV to Sales
5.11
PEG Ratio
NA
Dividend Yield
0.68%
ROCE (Latest)
-28.46%
ROE (Latest)
-11.07%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'09 - YoY
Jun'09
Jun'08
Change(%)
Net Sales
203.30
145.00
40.21%
Operating Profit (PBDIT) excl Other Income
91.40
84.60
8.04%
Interest
0.00
0.00
Exceptional Items
-83.20
-4.10
-1,929.27%
Consolidate Net Profit
65.10
64.80
0.46%
Operating Profit Margin (Excl OI)
402.40%
525.70%
-12.33%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2009 is 40.21% vs 114.81% in Jun 2008
Consolidated Net Profit
YoY Growth in quarter ended Jun 2009 is 0.46% vs 25.10% in Jun 2008
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
2,055.90
2,536.50
-18.95%
Operating Profit (PBDIT) excl Other Income
-135.70
-128.90
-5.28%
Interest
297.60
245.60
21.17%
Exceptional Items
145.60
-1,891.70
107.70%
Consolidate Net Profit
-284.70
-2,697.40
89.45%
Operating Profit Margin (Excl OI)
-103.90%
-216.50%
11.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -18.95% vs -36.06% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 89.45% vs -1,061.64% in Dec 2022
About Sihuan Pharmaceutical Holdings Group Ltd. 
Sihuan Pharmaceutical Holdings Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






